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YeastYeast Fba1 (fructose 1,6-bisphosphate aldolase) is a glycolytic enzyme essential for viability. The overproduction
of Fba1 enables overcoming of a severe growth defect caused by a missense mutation rpc128-1007 in a gene
encoding the C128 protein, the second largest subunit of the RNA polymerase III complex. The suppression of
the growth phenotype by Fba1 is accompanied by enhanced de novo tRNA transcription in rpc128-1007 cells.
We inactivated residues critical for the catalytic activity of Fba1. Overproduction of inactive aldolase still
suppressed the rpc128-1007phenotype, indicating that the function of this glycolytic enzyme in RNA polymerase
III transcription is independent of its catalytic activity.
Yeast Fba1 was determined to interact with the RNA polymerase III complex by coimmunoprecipitation.
Additionally, a role of aldolase in control of tRNA transcription was conﬁrmed by ChIP experiments. The results
indicate a novel direct relationship between RNA polymerase III transcription and aldolase.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Transcription by the three eukaryotic RNA polymerases requires a
number of accessory factors. RNA polymerase III (Pol III) is specialized
in the synthesis of tRNA, 5S rRNA and other untranslated RNAs. Yeast
Pol III consists of 17 subunits which have structural and functional
homologs in human cells. Transcription of tRNA genes requires the
multisubunit initiation factors TFIIIB and TFIIIC which speciﬁcally bind
to internal control regions [1,2].
Relatively small set of modulators has been reported to stimulate or
inhibit basal transcription by the core Pol III machinery in yeast
Saccharomyces cerevisiae. Efﬁcient and faithful transcription of the U6
snRNA and some tRNA genes requires an HMG-like protein Nhp6p
[3,4]. In addition, a positive modulatory effect on the Pol III-dependent
expression of tRNA and 5S rRNA genes is excreted by a speciﬁc subset
of ribosomal proteins, in particular Rpl6Ap [5]. From the other hand,
negative regulation by nutritional and stress signaling pathways is me-
diated by Maf1, a general Pol III repressor conserved across eukaryotic
organisms from yeast to man [6].ose 1,6-bisphosphate aldolase;
d Biophysics, Polish Academy of
.: +48 22 5921312.Recent studies have revealed further levels of complexity in involv-
ing the mechanisms of Pol III complex assembly. According to a recent
model, RNA polymerases, including Pol III, assemble in the cytoplasm
and are subsequently imported to the nucleus [7,8]. The nuclear import
of Pol III subunits is known to be coordinated [9] but the mechanism is
unknown. Undoubtedly Pol III assembly and nuclear import require
multiple auxiliary factors, but only few, common for other Pols, are
recognized so far. Incorporation of Rbp5 subunit, occurring prior to
the transfer of polymerase complex to the nucleus, is controlled by
Bud27 prefoldin [10]. Other data support a model in which small GPN
GTPases serve essential functions in Pol II and Pol III biogenesis
upstream nuclear import dependent on Iwr1 protein [11]. The
speciﬁcity of Iwr1 towards Pol III transport to the nucleus is, however,
controversial [12].
The biogenesis of Pol III in the yeast S. cerevisiae has been successful-
ly studied by a genetic approach. Several conditionalmutations in genes
encoding Pol III subunits were screened for extragenic suppression by a
yeast genomic library on a high-copy-number vector [1]. Those studies
revealed dosage-dependent interactions between distinct Pol III
subunits, indicating speciﬁc inter subunit association patterns within
the quaternary structure of the enzyme [13]. Using the same approach,
we isolated multicopy suppressor genes that overcome defects caused
by a speciﬁc Pol III mutation but do not code for a structural component
of that enzyme. One of those suppressors, described in the present
report, is FBA1, which codes for the glycolytic enzyme fructose 1,6-
bisphosphate aldolase. The genetic interaction identiﬁed in this study
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Pol III in both yeast and human cells. The functional relationship
between Pol III transcription and aldolase function is discussed.
2. Materials and methods
2.1. Yeast strains, plasmids and media
The MJ15-9C (MATa rpc128-1007 SUP11 ade2-1 ura3-1 lys2-1 leu2-
3,112, his3) and isogenic wild-type strain MB159-4D (MATa SUP11
ade2-1 ura3-1 leu2-3,112 lys2-1 his3) of S. cerevisiae were described
previously [14,15]. Pol III mutants rpc31-236 [16], rpc160-112 [17],
rpc160-270 [18], rpc11-Sp [19] and rpc160-750 [20] were obtained
from the Service de Biologie Intégrative et Génétique Moléculaire,
CEA/Saclay (France). Strains YPH499 (MATa ura3-52 his3-Δ200 ade2-
101 trp1-Δ63 lys2-801 leu2-Δ1) and MW4415 (MATa ura3-52
his3-Δ200 ade2-101 trp1-Δ63 lys2-801 leu2-Δ1 RPC160::3HA::KanMX6)
[21] were used for coimmunoprecipitation. For the ChIP experiment
RPC160 allele in MB159-4D was replaced by RPC160::3HA::KanMX6.
rpc128-1007 mutant with RPC160::3HA::KanMX6 was obtained by
genetic cross.
pMJ31 plasmid cloned from yeast genomic library is a derivative of
pFL44L (2 μ, URA3) [22] and contains yeast genomic insert with 3′-
part ofMSN4, YKL061W, FBA1 and 3′ — part ofMPE1 gene. Deletion of
an SspI/PvuII restriction fragment from pMJ31 resulted in [YKL061W].
[FBA1] plasmid resulted from subcloning of a BamHI–NruI fragment of
pMJ31 into pFL44L digestedwithBamHI and SmaI. pLH3 plasmid (called
here [RPC128]), kindly provided by P. Thuriaux, contains RPC128 gene
on pRS316 (URA3 cen6 arsH4).
All yeast media (rich, minimal and sporulation media) were
prepared according to Sherman [23]. Rich yeast medium (2% peptone,
1% yeast extract) was supplemented with 2% glucose (YPD) or 2%
glycerol (YPGly). Minimal 2% glucose medium (SC) was supplemented
with appropriate amino acids as required. Yeast cells were transformed
with plasmid DNA using the lithium acetate method [24] and were
cultivated at 30 °C in SC medium lacking uracil for 3 days.
2.2. Mutagenesis of the FBA1 gene
Nucleotide substitutions in pFL44L-FBA1 plasmid (designated as
[FBA1]) were incorporated according to QuickChange site-directed
mutagenesis protocol (Stratagene). The oligonucleotides used in the in-
dividualmutagenesis reactionswere: 5′-GTCTTACACTCTGCCCACTGTGC
CAAG-3′ [fba1D110A], 5′-GTCTTACACTCTGACGCCTGTGCCAAGAAGTTG-
3′ [fba1H111A], 5′-ACCGGTGGTGAAGCAGATGGTGTTAACAACGAA-3 ′
[fba1E183A].
2.3. RNA preparation
The total RNA was isolated from yeast by the hot phenol method as
described previously [25]. Quantity and quality of RNA were analyzed
by NanoDrop 1000 (Thermo ND-1000) and veriﬁed by analysis on
ethidium bromide-stained agarose gels.
2.4. Northern blotting
To determine tRNA levels, 5 μg of the total RNA was resolved by 10%
PAGE with 8 M urea and transferred onto a Hybond-N+ membrane
(Amersham) by electroblotting in 0.5× TBE and crosslinked by UV
radiation. The membrane was prehybridized in phosphate buffer (7%
SDS, 0.5 M sodium phosphate pH 7.2, 1 mM EDTA pH 7.0, 1% BSA) and
hybridized for 3 h at 37 °C in the same solution with oligonucleotide
probes labeled with T4 polynucleotide kinase (Fermentas) and
[γ-32P]-ATP. The probes were: 5′-GCGCTCTCCCAACTGAGCT-3′ for
tRNA-Phe (GAA), 5′-TATTCCCACAGTTAACTGCGGTCA-3′ for the intron
of tRNA-Leu (CCA) and 5.8S rRNA, 5′-GCGTTGTTCATCGATGC-3′. Afterhybridization, blots were washed 3 × 10 min with 1 × SSC, 1% SDS
and 3 × 10minwith 0.5 × SSC, 0.1% SDS at 37 °C and exposed to a phos-
phor imaging screen (Fujiﬁlm).
To determine levels of FBA1 mRNA, 10 μg of the total RNA
denaturated in a glyoxal reaction mixture at 55 °C for 1 h was resolved
by electrophoresis in 1.4% agarose gel in 1× BPTE buffer (10 mM PIPES,
30 mM Bis–Tris, 1 mM EDTA pH 8.0), and transferred into a Hybond-
N+ membrane (Amersham) with 10 × SSC using the TurboBlotter
downward capillary transfer system (Schleicher & Schuell) and
crosslinked by UV radiation (0.14 J/cm2). The blot was prehybridized
for 3 h at 65 °C in phosphate buffer (described above) and hybridized
with FBA1 probe (150 bp PCR fragment ampliﬁed using primers 5′-
CAAAGTTGGTTGCAAGGAAG-3′ and 5′-GATACCAGTCAAGTAAGCG-3′)
and ACT1 probe (193 bp PCR fragment ampliﬁed with primers 5′-
TGAAGTGTGATGTCGATGTC-3′ and 5′-GCCAAGATAGAACCACCAAT-3′).
The probes were labeled with [α-32P]-ATP by random priming using
the DecaLabelTM DNA labeling kit (Fermentas). Hybridization was
carried out overnight at 65 °C in the same buffer as prehybridization.
Filters were washed ﬁve times (10–15 min each) with 2 × SSC, 0.1%
SDS at 37 °C. Hybridization signalswere exposed to a phosphor imaging
screen. RNAwas quantiﬁed using FLA-7000 PhosphorImager (Fujiﬁlm).
Band intensities were quantiﬁed using MultiGauge v3.0 Software
(Fujiﬁlm). The statistical signiﬁcance was computed using a t-test as
implemented in the OpenOfﬁce.org.
2.5. Western blotting
Total cellular protein was extracted from yeast cells by alkaline lysis
as described previously [15]. Proteins separated by 8% or 10% SDS-PAGE
were transferred electrophoretically to nitrocellulose membrane. The
membrane was blocked for 30 min in TBST (10 mM Tris, 150 mM
NaCl, 0.05% Tween20) containing 5% fat-free drymilk and then incubat-
ed with mouse monoclonal antibodies as the following: anti-HA
(Covance) at 1:5000 dilution for 2 h, anti-Vma2 (Molecular Probes) at
1:10,000 dilution for 1 h and anti-Fba1 rabbit polyclonal antibody
(GenScript) at 1:10,000 dilution for 0.5 h. The membrane was then
incubated with secondary polyclonal goat anti-mouse or anti-rabbit
antibodies coupled with horseradish peroxidase (DAKO), which was
visualized with a chemiluminescence detection kit (Millipore).
2.6. Immunoﬂuorescence
S. cerevisiae cells were ﬁxed in culture by adding formaldehyde to a
ﬁnal concentration of 3.7% for 1 h, spun down, washed and converted
to spheroplasts, which were applied on microscopic slides covered
with polylysine and subsequently treated as described previously [21].
Anti-yeast Fba1 antibody (1:500 for 0.5 h) was added followed by sec-
ondary Cy3-conjugated anti-rabbit antibody (1:250 for 0.5 h). A Carl
Zeiss Axio ImagerM2 microscope equipped with a 100× oil objective
was used. Images were collected with the AxioVision 4.8 program.
2.7. Coimmunoprecipitation
Yeast cells expressing either HA epitope-tagged Rpc160 (MW4415)
or untagged Rpc160 (YPH499) were grown to an exponential phase in
rich glucosemedium(YPD) at 30 °C. Cells (40ml culture)were pelleted,
resuspended in 0.5 ml of IP buffer (50 mMHepes-KOH pH 7.5, 100 mM
NaCl, 1 mM EDTA, 0.05% Nonidet P-40, 0.5 mM DTT, 5% glycerol,
cOmplete Protease Inhibitor; Roche) and broken with glass beads
using a Vibramax disruptor (IKA) at maximum speed for 30 min at
4 °C. Protein concentration was determined with the Bio-Rad protein
assay. One milligram of the total protein extract was incubated for 2 h
with 5 μg of rabbit polyclonal anti-yeast Fba1 antibody with gentle
shaking at room temperature in Mobicol F columns (MoBiTec) equili-
bratedwith IP buffer. Then, 100 μl of a 75% slurry of Protein A-Sepharose
CL-4B (Healthcare GE) previously washed according to manufacturer's
Table 1
FBA1 is a speciﬁc suppressor of the rpc128-1007mutation.
Mutant tested Growth conditions Suppression by FBA1
rpc31-236 YPD or YPGly at 37 °C; YPD at 16 °C No
rpc160-270 YPD or YPGly at 37 °C; YPD at 16 °C No
rpc160-112 YPD at 37, 34 and 16 °C or YPGly at 37 °C No
rpc11-Sp YPD at 16 °C or YPGly at 37 °C No
rpc160-750 YPD at 34 and 16 °C or YPGly at 37 °C No
rpc128-1007 YPD at 30 and 16 °C Yes
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the incubation with gentle shaking was continued for 1 h at room tem-
perature. Subsequently theﬂow throughwas collected and the columns
were washed three times with IP buffer. Bound proteins were eluted
with 200 μl of elution buffer (0.1 M glycine-HCl pH 2.5). After
concentration the entire column fraction was analyzed by 8% SDS-
PAGE followed byWestern blottingwith anti-Fba1 or anti-HA antibody.
2.8. Determination of Fba1 aldolase activity in yeast extracts
To prepare cell-free extracts, culture samples were harvested,
washed twice with 10 mM potassium phosphate buffer (pH 7.5) con-
taining 2 mM Na2H2-EDTA, concentrated 10-fold by centrifugation
and stored at −20 °C. Samples were thawed, washed in 100 mM
potassium phosphate buffer (pH 7.5) containing 2 mM MgCl2. and
resuspended in an equal volume of this buffer. Cell-free extracts were
prepared using the FastPrep method with bead-based homogenizer
and acid-washed glass beads (425–600 μm; SigmaAldrich). Eight bursts
of 15 s each at a setting of 6.0 were administered. In between the bursts,
samples were cooled on ice for at least 30 s.
Aldolase activity was measured in concentrated cell-free yeast
extracts [26]. The reaction rates were measured in NADH-linked assays
set up with coupling enzymes [27]. NADH concentration change over
time was monitored by measuring absorbance at 340 nm. The assay
mixture contained 50 mM Tris–HCl (pH 7.5), 100 mM KCl, 0.15 mM
NADH, 2.4 U ml−1 of glycerol-3-phosphate dehydrogenase (Roche),
82 U ml−1 of triosephosphate isomerase (Sigma Aldrich), and cell ex-
tract. The reaction was started with an addition of 20 mM fructose
1,6-bis-phosphate. For spectroscopic measurements, medium through-
put analysis was employed by using an automated analyzer Synergy HT
(BioTek). Protein concentration was determined by the Bradford pro-
tein assay. Aldolase activity is expressed as μmol of substrate converted
per min per mg of extracted protein (μmol min−1 mg protein−1).
2.9. Chromatin immunoprecipitation (ChIP)
Yeast chromatin isolation and sonication were prepared according
to Graczyk et al. [28]. Cells (17 OD600 units) were grown to an exponen-
tial phase in SC-ura medium.
The preparation of magnetic beads, immunoprecipitation (anti-HA),
elution from beads, decrosslinking and DNA puriﬁcation were done as
described previously [29].
Samples were analyzed by quantitative PCR as described [28]. The
primers were: 5′-ATCGACATCGCTCACTTGAG-3′ and 5′-CCTTGTGCAA
CAACCTAC-3′ to amplify tRNA-Leu (CAA), 5′-GCACATTCTCGTGCGTTT
AAAC-3′ and 5′-CCTTTTTGTCGTCCCTAGGAATT-3′ to amplify tRNA-Phe
(GAA) and 5′-CTGTCAGAATATGGGGCCGTAG-3′ and 5′-CCATACCCTC
GGGTCAAACAC-3′ to amplify fragment of chromosome V (ARS504)
which served as control.
ChIP was performed on growing HeLa cells, as described previously
[30], using the following antibodies: monoclonal mouse anti-human
aldolase A (Abcam 54770), polyclonal goat anti-human aldolase A
(Abcam 6190), polyclonal rabbit anti-human POLR3A (against the largest
subunit RPC1 of 155 kDa; Abcam 96328) and control IgG (Abcam). The
primers used to amplify the human genes were the same as applied be-
fore [31–33]: 5S rRNA, forward 5′-GGCCATACCACCCTGAACGC-3′, reverse
5′-CAGCACCCGGTATTCCCAGG-3′; tRNA-Arg, forward 5′-GGCTCTGTGG
CGCAATGGATA-3′, reverse 5′-TTCGAACCCACA ACCTTTGAATTGCTC-3′;
tRNA-Tyr, forward 5′-CCTTCGATAGCTCAGCTGGTAGAGCGGAGG-3′,
reverse 5′-CGGAATTGAACCAGCGACCTAAGGATGTCC-3′; U6-1 snRNA
gene, forward 5′-GTACAAAATACGTGACGTAGAAAG-3′, reverse 5′-GGTG
TTTCGTCCTTTCCAC-3′; U1, forward 5′-CACGAAGGAGTTCCCGTG-3′, re-
verse 5′-CCCTGCCAGGTAAGTATG-3′; U6-4 snRNA (inactive Pol III gene)
forward 5′-TTCCTGCGATTCAAACTTAACTGG-3′, reverse 5′-AAATGTAA
CCTATTTTTAAATATTAGCACA-3′ and 1α,25-dihydroxyvitamin D3 24-hydroxylase (24(OH)ase), forward 5′-GGGAGGCGCGTTCGAA-3′, reverse
5′-TCCTATGCCCAG-GGAC-3′.
3. Results
3.1. Overexpression of the FBA1 gene overcomes the growth defect and
elevates pre-tRNA synthesis in the rpc128-1007 yeast mutant
rpc128-1007 is a cold-sensitive missense mutation Gly1007Ala in the
yeast gene encoding the second-largest subunit of Pol III, C128 [15].
Glycine 1007 is conserved in B150, the second-largest subunit of yeast
Pol II, as well as in prokaryotic homologs, the β subunits from Escherichia
coli and Bacillus subtilis. The rpc128-1007mutation is located very close (6
amino acids upstream) to the nucleotide binding motif (G995X4GK1001)
and near the zinc ﬁnger motif (C1095X2CGX9–15CX2C1110) (where X is
any amino acid). The MJ15-9C strain carrying the rpc128-1007mutation
showed no growth at 16 °C (cold-sensitive phenotype cs) and slower
growth at 30 °C. The cs phenotype was complemented by the RPC128
gene introduced on a single copy plasmid (data not shown). Analysis of
the total RNA on ethidium-bromide stained gel showed that tRNA levels
were 1.6-fold reduced relative to the level of 18S rRNA in the rpc128-
1007mutant compared to a wild-type strain [15].
Starting with rpc128-1007, we isolated multicopy suppressors by
transforming the mutant strain MJ15-9C with a wild-type yeast
genomic library borne on the multicopy vector pFL44L [22] and
selecting colonies that grew at the restrictive temperature 16 °C. For
each transformant, we checked that plasmid extraction and retransfor-
mation of the original mutant strain suppressed its phenotype and that
removing the suppressor plasmid restored the mutant phenotype. The
ﬁrst class of four transformants exhibited a wild-type growth rate at
16 °C and harbored plasmids with the RBS1 gene of unknown function.
The remaining transformant plasmids only partially restored growth at
16 °C. Sequencing one of them identiﬁed a genomic insert derived from
chromosome XI; subsequent subcloning of that plasmid led to the
identiﬁcation of the FBA1 gene, which complemented the cs growth
phenotype of rpc128-1007 (Supplementary material; Fig. S1). FBA1
encodes fructose 1,6-bisphosphate aldolase, which catalyzes the
conversion of fructose 1,6-bisphosphate (FBP) to glyceraldehyde-3-
phosphate (G3P) and dihydroxyacetone phosphate (DHAP) in glycoly-
sis and the reverse reaction of gluconeogenesis.
We were also interested whether other mutants in the yeast Pol III
machinery could be suppressed by an increased dosage of the FBA1
gene that complemented the phenotype of the rpc128-1007mutation.
Several available Pol III mutants defective in initiation (rpc31-236), elon-
gation (rpc160-112, rpc160-270) and termination (rpc11-Sp, rpc160-
750) of tRNA transcription were transformed with the pFL44L plasmid
carrying the FBA1 gene. The growthof the transformantswas subsequent-
ly tested on glucose or glycerol medium at temperatures suitable for the
individual mutants (Table 1). We found that the suppression by the
FBA1 overdose is unique to the rpc128-1007mutation because no defect
of other Pol III mutants tested was complemented. This indicated that
FBA1 corrected a speciﬁc function of Pol III defective in rpc128-1007 cells.
Although the Fba1 protein has generally been considered a house-
keeping protein involved in glucose metabolism, systematic analyses of
protein complexes in yeast have repeatedly identiﬁed Fba1 in complexes
with Pol III subunits and Maf1, the Pol III repressor [34,35]. The Fba1
Table 2
Aldolase activity in rpc128-1007 cells. The wild-type strain MB159-4D (wt) and the
rpc128-1007 mutant MJ15-9C transformed with the empty vector pFL44L (rpc128-1007
[−]), the pLH3 derivative of the pRS316 plasmid encoding RPC128 (rpc128-1007
[RPC128]), or plasmids harboring the native or mutated FBA1 gene (rpc128-1007[FBA1];
rpc128-1007[fba1D110A]; rpc128-1007[fba1H111A]; rpc128-1007[fba1 E183A]) were
grown to the exponential phase in glucose medium (YPD). Cell-free extracts were used
for enzyme assays as described in Materials and methods. Standard errors of the mean
(SEM) of at least four independent experiments are given.
Yeast strain Aldolase activity (μmol min−1 mg protein−1)
wt[−] 0.85 ± 0.12
wt[FBA1] 3.82 ± 0.51
rpc128-1007[−] 0.70 ± 0.1
rpc128-1007[RPC128] 0.77 ± 0.07
rpc128-1007[FBA1] 4.9 ± 0.96
rpc128-1007[fba1D110A] 0.66 ± 0.07
rpc128-1007[fba1H111A] 0.61 ± 0.1
rpc128-1007[fba1 E183A] 0.68 ± 0.08
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directly involved in Pol III control. We thus checkedwhether an overdose
of FBA1 could correct the low tRNA levels in rpc128-1007 cells. To evaluate
the effect of FBA1 on de novo tRNA synthesis, we employed northern
hybridization using speciﬁc oligonucleotide probes that identify tRNA
precursors. Cells were grown in glucose medium at 30 °C and shifted to
the restrictive temperature of 16 °C for 2 h. The level of 5.8S rRNA was
comparable in rpc128-1007 and wild-type cells and thus served as an
internal control. We monitored the synthesis of two representative
intron-containing tRNAs, tRNA-Leu (CAA) and tRNA-Phe (GAA)
(Fig. 1A). The levels of tRNA precursors, both unprocessed initial tran-
scripts and end-matured intron-containing pre-tRNAs, were more than
two-fold decreased in the rpc128-1007mutant relative to the wild-type
control (Fig. 1B), conﬁrming the defect in the de novo tRNA synthesis.
In accordancewith the suppressionof the growthdefect, the FBA1overex-
pression increased the levels of the two tRNA precursors in rpc128-1007
cells but had no effect on pre-tRNA levels in the control wild-type strain.
These results indicate that an overdose of FBA1 corrects the speciﬁc Pol III
defect in the rpc128-1007mutant.
3.2. Relationship between tRNA transcription and Fba1 expression/
enzymatic activity
The requirement of an FBA1 overdose for activation of Pol III tran-
scription in rpc128-1007 yeast cells suggested a reduced endogenousFig. 1.The FBA1 suppressor partially corrects lowpre-tRNA-Leuand pre-tRNA-Phe levels in the r
wild-type (wt) control strain (MB159-4D) transformed with the empty vector [−] or the plas
(A) RNA was analyzed by northern blotting using probes speciﬁc for pre-tRNA-Leu (CAA) a
speciﬁc oligonucleotide probes are speciﬁed in Materials and methods. Positions of initial tran
(B) Pre-tRNA forms of tRNA-Leu and tRNA-Phe were quantiﬁed. Bars represent levels for pr
P-value calculated for pre-tRNAs rpc128-1007[−] / wt[−] and rpc128-1007[−] / rpc128-1007[Fba1 level in those cells. Levels of FBA1 mRNA and Fba1 protein were,
however, unchanged in rpc128-1007 when compared to the control
wild-type strain (Supplementary material, Fig. S2). Likewise, enzymatic
reactions carried out with freshly prepared extracts showed no signiﬁ-
cant effect of rpc128-1007 on the fructose bisphosphate aldolase activity
(Table 2). We thus concluded that decreased tRNA transcription in the
rpc128-1007mutant is not correlatedwith lower efﬁciency of glycolysis.pc128-1007 strain. Total RNAwas isolated from the rpc128-1007mutant (MJ15-9C) and the
mid harboring FBA1 [FBA1]. Cells were grown in YPD at 30 °C and shifted to 16 °C for 2 h.
nd tRNA-Phe (GAA). 5.8S rRNA served as the loading control. The sequences of tRNA-
scripts, end-processed intron-containing pre-tRNA (IVS) and mature tRNA are indicated.
imary transcripts and intron-containing precursors normalized to loading control. The
FBA1] showed statistical signiﬁcance (p b 0.01).
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pression and activity of Fba1 aldolase (Supplementary material; Fig. S2
and Table 2). This observation raised a question whether the ﬁve-fold
higher catalytic activity of aldolase accounts for stimulation of tRNA
transcription in rpc128-1007 cells. We therefore created catalytic Fba1
mutants to see whether overproduction of inactive aldolase could still
suppress the rpc128-1007 phenotype.
Yeast Fba1 is a homodimeric enzyme and belongs to the class II
fructose-bisphosphate aldolase family, which is present only in bacteria,
protozoa, fungi and blue-green algae (referred in [36]). The E. coli aldol-
ase contains two zinc ions per enzyme dimer that are absolutely
required for enzyme activity [37]. The zinc is coordinated by three
histidine residues, which are conserved between E. coli and yeast. One
of them is histidine 111, which we substituted to alanine in yeast Fba1
assuming that the catalytic function of the enzymewould be inactivated
as it was experimentally proven for E. coli. Based on biochemical data
and the structure of bacterial class II aldolases, we also created two
other Fba1 mutants, D110A and E183A. Homologous amino acids of
the E. coli and Mycobacterium tuberculosis class II aldolases affect
substrate binding and kinetic parameters of the enzyme [36–38].
In bacteria, the catalytic activity of class II aldolase is indispensable
for survival [36]. Aldolase is also essential in yeast and thus the fba1Δ
strain of S. cerevisiae is not viable. To determine whether our fba1
mutants were viable, each mutant allele was introduced to the hetero-
zygous diploid fba1Δ/FBA1 on the plasmid. After sporulation, only two
spores from each tetrad were grown (Supplementary material;
Fig. S3). The PCR analysis of representative spores from each diploid
showed that they carried the active FBA1 chromosomal gene. All three
fba1mutants were lethal because none of them complemented fba1Δ.
We anticipated that the created amino acid substitutions in Fba1 led
to inactivation of the essential catalytic function of aldolase. Multicopy
plasmids encodingmutated fba1 alleleswere independently introduced
to rpc128-1007 cells. Mutated forms of aldolase are efﬁciently produced
and stable (Supplementary material; Fig. S4). Increased expression of
fba1H111A, fba1D110A and fba1E183A on the background of chromo-
somal active FBA1 led to suppression of the rpc128-1007 growth pheno-
type (Fig. 2). As expected, no increase in aldolase activity was observed
in rpc128-1007 upon overproduction of mutated Fba1 forms (Table 2).
Altogether, the overproduction of Fba1 protein but not aldolase ac-
tivity is essential to overcome the growth defect related to decreased
tRNA transcription in rpc128-1007 cells. Thus, the Fba1 function in Pol
III transcription is independent of its catalytic activity.3.3. Fba1 is localized in the cytoplasm and nucleus
Polyclonal antibodies were used to localize Fba1 in yeast cells by im-
munoﬂuorescence. As shown in Fig. 3, the Fba1-speciﬁc ﬂuorescence
signal was uniformly distributed throughout the cell in glucosemedium
(YPD). Thus, Fba1 is not excluded from the nucleus although its functionFig. 2. Increased FBA1 expression but not aldolase activity is required for suppression of the rpc1
aldolase [fba1D110A], [fba1H111A], [fba1E183A] or empty vector pFL44L [−] were introduced to
with the empty vector or the [FBA1] plasmid served as a control. Transformants were patchedin glycolysis is associated with a cytoplasmic localization. Signiﬁcantly,
mammalian Fba1 is also localized in the cytoplasm and nucleus [39,40].
We explored the possibility that physiological changes affecting
Pol III transcription would also affect Fba1 expression and subcellular
localization. The switch between glucose medium and one with a
nonfermentable carbon source causes widespread changes in gene
transcription, including repression of Pol III transcription. However,
we determined no differences in Fba1 protein level or its subcellular
distribution between glucose- and glycerol-grown yeasts (data not
shown).
3.4. Yeast Fba1 aldolase interacts physically with the Pol III complex
Because Fba1 is not excluded from the nucleus and potentially inter-
acts with Pol III as suggested by systematic analyses of protein com-
plexes in yeast [34,35], we used coimmunoprecipitation experiments
to test whether yeast Fba1 and Pol III were able to interact with each
other. Crude extracts were prepared from yeast cells expressing HA-
tagged Rpc160, the largest Pol III subunit C160, and control wild-type
cells with untagged Rpc160. Cells were grown in glucose medium to
the exponential phase. Fba1 was immunoprecipitated from the cell ex-
tractswith a speciﬁc polyclonal anti-yeast Fba1 antibody and the immu-
noprecipitates were examined for the presence of Rpc160 protein by
immunoblotting using anti-HA antibody. As shown in Fig. 4, Rpc160
was selectively coimmunoprecipitated with Fba1 (compare lane 4 and
control lanes 3 and 5). This result indicates that Fba1 and Pol III interact
with each other.
3.5. Aldolase is involved in Pol III control on chromatin
The established Pol III–Fba1 interaction prompted us to investigate
the effect of aldolase on Pol III association with chromatin. We used as
a control wild-type strain and an isogenic rpc128-1007mutant, both ex-
pressing HA-tagged Pol III subunit C160 (Rpc160-HA), to perform the
ChIP analysis followed by real-time quantitative PCR (Fig. 5A). Clearly
mutation in the Pol III subunit C128 led to lower association of Pol III
with chromatin as compared to isogenic wild-type strain. Importantly,
overproduction of aldolase in rpc128-1007 mutant resulted in signiﬁ-
cantly increased Pol III occupancy on tRNA genes, association with
tRNA-Leu (CAA) was increased by 3.2 ± 0.9 fold and with tRNA-Phe
(GAA) by 2.5 ± 0.7 fold. These data indicate that aldolase promotes
Pol III association with chromatin. Unfortunately, the ability of
aldolase-speciﬁc antibodies to precipitate the enzyme under ChIP con-
ditions was too low and we were unable to estimate Fba1occupancy
on Pol III genes.
Three tissue-speciﬁc Fba1 orthologs, commonly referred as A, B and
C, exist in mammals. These aldolase isoenzymes, which have been
primarily described as participating in glucose metabolism in the cyto-
plasm, have also been detected in the nuclei and seem to be engaged
in undeﬁned nuclear functions [39–41]. Knowing that yeast Fba128-1007 growth phenotype. Plasmids encodingwild-type [FBA1] andmutated versions of
the rpc128-1007mutant (MJ15-9C strain). The wild-type strain (MB159-4D) transformed
on SC-ura medium, replica-plated on YPD medium and incubated at 16 °C for 7 days.
Fig. 3. Fba1 is uniformly distributed throughout the yeast cell. Thewild-type strainMB159-4D (wt) and the rpc128-1007mutantMJ15-9C, transformedwith the empty vector pFL44L [−]
or the [FBA1] plasmid,were grown to the exponential phase inYPDat 30 °C and shifted to 16 °C for 2 h. Fba1 localizationwas analyzedby immunoﬂuorescencemicroscopyusing anti-Fba1
antibody. Nuclei were stained with DAPI.
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human aldolase with Pol III genes by ChIP. We used two different anti-
bodies against aldolase A, the form found mostly in the nucleus [40].
Both antibodies precipitated chromatin fragments containing Pol III
genes, the 5S rRNA, both tRNA-Arg and tRNA-Tyr genes and the active
U6-1 snRNA gene (Fig. 5B). Pol III was also precipitated with these
genes. In contrast, aldolase was not associated with the silent U6-4
snRNA gene and the Pol II genes encoding U1 snRNA and 1α,25-
dihydroxyvitamin D3 24-hydroxylase (24(OH)ase), demonstrating
that aldolase associates speciﬁcally with active Pol III genes. These
data indicate that aldolase is present in Pol III chromatin in human
cells, suggesting its direct role in Pol III transcription.Fig. 4. Yeast aldolase interacts with the Pol III complex. Strain MW4415 expressing
HA-tagged Rpc160 (lanes 2, 4, 5) and control strain YPH499 expressing untagged
Rpc160 (lanes 1, 3) were grown to the exponential phase. Cell extracts were incubated
with anti-Fba1 polyclonal antibody followed by Protein A Sepharose. Immunoprecipitated
proteins were eluted and subjected to SDS-PAGE. Aliquots of cell extracts (lanes 1, 2),
immunoprecipitates with the Fba1 antibody (lanes 3, 4) and proteins bound to Protein
A Sepharose without antibody (lane 5) were analyzed by immunoblotting with anti-
Fba1 and anti-HA antibodies. Molecular weight of Fba1 protein is 39.6 Da; weight of
C160 with HA-tag is above 160 Da.4. Discussion
The FBA1 gene of S. cerevisiaewas cloned in our laboratory bymeans
of a genetic screen as a multicopy suppressor of the growth phenotype
of the rpc128-1007mutation in a gene encoding the Pol III subunit. FBA1
encodes the glycolytic enzyme fructose 1,6-bisphosphate aldolase,
which is essential for cell viability. Genetic suppression is functional
because the overproduction and increased activity of Fba1 aldolase
enhanced de novo tRNA transcription in rpc128-1007 yeast cells. More-
over, overproduction of the Fba1 protein but not an increase of aldolase
activity is necessary for the suppression of the rpc128-1007 phenotype.
This indicates that, in addition to its function in glycolysis, Fba1 plays a
role in control of Pol III transcription. We further showed that aldolase
physically interacts with Pol III complex. Additionally, Fba1 overdose
increases Pol III association with tRNA genes in rpc128-1007 yeast cells
and human aldolase is associated with Pol III chromatin in HeLa cells.
Altogether the results presented here indicate that aldolase possesses
a previously unsuspected inﬂuence on Pol III transcription in the
nucleus.
Secondary functions have been implicated for aldolases from various
organisms. Non-glycolytic function in host–pathogen interactions has
been suggested for aldolase from M. tuberculosis [42]. Yeast gene
encoding Fba1 has been cloned as amulticopy suppressor of themutant
affecting G1-speciﬁc transcription [43]. Mammalian aldolase is impli-
cated in endocytosis by speciﬁc interaction with WASP/Arp2/3 protein
controlling actin polymerization [44] and by a non-glycolytic
mechanism affects cancer cells proliferation [45]. Noteworthy, aldolase
knockdown inhibited cell proliferation by 90% and this was rescued by
enzymatically dead variant [45]. An independent study localized mam-
malian aldolase in the heterochromatin region in the nuclei of
cardiomyocytes and smooth muscle cells [41] as well as in the nuclei
of cancer cells [40]. Signiﬁcantly, nuclear localization of aldolase is a dy-
namic process dependent on the availability of energetic substrates and
Fig. 5. Aldolase is involved in Pol III control on chromatin. A. Overproduction of yeast aldolase in rpc128-1007 cells increases relative occupancy of Pol III on selected genes. Wild type and
rpc128-1007 strains expressing HA-tagged Rpc160were transformedwith the empty vector [−] or the plasmid harboring FBA1 [FBA1]. Cells were grown in SC-ura at 30 °C to exponential
growth phase. Cross-linked chromatin was immunoprecipitated with antibody against HA epitope, followed by quantitative PCR. Occupancies of Pol III at tRNA-Leu and tRNA-Phe genes
weremeasured relative to its occupancy on untranscribed fragment of chromosomeV (ARS504). B. Human aldolase associateswith active Pol III genes inHeLa cells. ChIPwasperformedon
cross-linked chromatin from growingHeLa cells using an anti-aldolase A goat antibody and anti-Pol III antibody. The genes investigated are depicted below the bars: the 5S rRNA gene, the
tRNA-Arg and tRNA-Tyr genes and the active U6-1 snRNA gene, the inactive U6-4 snRNA gene, the Pol II U1 snRNA genes and the 1α,25-dihydroxyvitaminD3 24-hydroxylase (24(OH)ase
gene. The signals are presented as % of input signal of three separate experiments with standard deviations.
1109M. Cieśla et al. / Biochimica et Biophysica Acta 1843 (2014) 1103–1110correlated with proliferation and cell cycle progression [40]. All these
data implicate important function of aldolase in the nuclear compart-
ment which has not been recognized yet.
Here we show that in the nucleus aldolase possesses a previously
unsuspected inﬂuence on Pol III transcription. For higher eukaryotes,
Pol III regulation is linked to cell proliferation, and several important
cell cycle regulators (such as p53, Myc, and Rb) regulate Pol III. In addi-
tion, up-regulation of Pol III transcription is a common feature of cancer
cells and may contribute to their proliferation [46].
It is possible that the effect of aldolase on proliferation of cancer cells
[40,45] is mediated by Pol III activation. An unanswered question
remains, however,what regulatory event in Pol III systemis being affect-
ed by aldolase. Since our data show interaction of aldolase with Pol III
complex at the chromatin level, it is unlikely that aldolase plays a role
in Pol III assembly in the cytoplasm. It has been shown previously thatactin plays a role in nucleoskeleton, is associated with Pol III complex
and localized to actively transcribed Pol III gene U6 [47]. On the other
hand, it is known that aldolase is involved in controlling actin polymer-
ization [44]. Thus, it is possible that aldolase provides a link between Pol
III transcription and actin dynamics.
Whether the relationship between Pol III transcription and aldolase
is conserved between yeast and humans remains enigmatic. Compo-
nents of Pol III complex in yeast have structural and functional
homologs in human cells and share a conserved core which is closely
related to the archaeal polymerase [48]. In contrast, aldolases from
yeast and human are not related to each other by sequence, structure
and catalytic mechanism which they use. Yeasts have class II (metallo)
aldolase and humans have class I (Shiff-base) aldolase; since prokary-
otes have class I aldolase too, both aldolase classes assumed to be evolu-
tionary ancient [49]. With the identiﬁcation of the new class IA aldolase
1110 M. Cieśla et al. / Biochimica et Biophysica Acta 1843 (2014) 1103–1110in the archaea [50],which shows no sequence similarity to classical class
I and II enzymes and is not evolutionary related with them, one cannot
consider that a common ancestor of aldolasewhich existed before Pol III
emerged in the eukaryotic lineage. Nevertheless our work supports the
hypothesis that aldolase function in Pol III transcription is not limited to
yeast but extended to higher eukaryotes.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.02.007.
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